Clinical Trial Update: Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease [NA]

View source ↗

Summary

A clinical trial from Imperial College London is evaluating a TSPO-targeted approach to improve brain endothelial cell function in cerebral small vessel disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease

Snippet

Sponsor: Imperial College London | Conditions: Cerebral Small Vessel Disease | NA | Status: RECRUITING